Drugs / Morphine Prolonged Release
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01964378 Comparator | Oct 2013 → Oct 2015 | chronic pain syndrome, neoplasm | Tris Pharma, Inc. | Terminated | Met primary Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Morphine Prolonged Release | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01964378 ↗ |
| Route | Oral | “Twice daily oral administration” NCT01964378 ↗ |